Chromsystems Newborn Screening
Chromsystems' assays enable efficient and reliable determination of amino acids and acylcarnitines from dried blood spot samples as part of the newborn screening for amino acid and fatty acid metabolic disorders using tandem mass spectrometry. Learn more about the respective assays and find most of their advantages at the Gulf Scientific Corporation stand at MedLab 2019; details include:
• CE-IVD validated and ready-to-use assays by LC-MS/MS
• Each analyte safeguarded by its own internal standard
• Fast and robust sample preparation
• Screening for many metabolic disorders in a single run such as PKU (Phenylketonuria), MSUD (Maple Syrup Urine Disease) and tyrosinemia type I.